Comparison between Kilitch Drugs (india) Rights Issue 2025 and Valiant Laboratories Limited Rights Issue 2025.
Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Kilitch Drugs (india) Rights Issue 2025 and Valiant Laboratories Limited Rights Issue 2025. Kilitch Drugs (india) Rights Issue 2025 is listed on BSE, NSE while Valiant Laboratories Limited Rights Issue 2025 is listed on BSE, NSE.
| Kilitch Drugs (india) Ltd. | Valiant Laboratories Limited | |
|---|---|---|
| Logo |  |  |
| Listing At | BSE, NSE | BSE, NSE |
| Terms of Payment | The full amount of the Issue Price Rs 357/- will be payable on application. | As per Terms of Payment, The Full amount of the Issue Price, being Rs . 75/- per share, will be payable on Application. |
| Entitlement | 2 Rights Equity Share(s) for every 23 fully paid-up Equity Shares held on Record Date | 1 Rights Equity Share(s) for every 4 fully paid-up Equity Shares held on Record Date |
| Application Form | Application Form  | Application Form |
| Letter of Offer | Letter of Offer | Letter of Offer |
| Registrar | MUFG Intime India Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Lead Managers |
The issue size of Kilitch Drugs (india) Rights Issue 2025 rights issue is ₹49.93 Crores, whereas Valiant Laboratories Limited Rights Issue 2025 rights issue size is ₹81.47 Crores.
| Kilitch Drugs (india) Ltd. | Valiant Laboratories Limited | |
|---|---|---|
| Issue Size | 13,98,463 shares | 1,08,62,500 shares |
| Issue Size (Amount) | ₹49.93 Crores | ₹81.47 Crores |
| Issue Price | ₹357 per share | ₹75 per share |
| Face Value | ₹10 per share | ₹10 per share |
Find all the important dates related to the rights issue. The record date of Kilitch Drugs (india) Rights Issue 2025 is Jul 15, 2025 while record date of Valiant Laboratories Limited Rights Issue 2025 is Jul 19, 2025.
| Kilitch Drugs (india) Ltd. | Valiant Laboratories Limited | |
|---|---|---|
| Record Date | Jul 15, 2025 | Jul 19, 2025 |
| Credit of Rights Entitlements | Jul 16, 2025 | Jul 21, 2025 |
| Bid/Offer Opens On | Jul 23, 2025 | Jul 28, 2025 |
| Renunciation of Rights Entitlements | Aug 18, 2025 | Aug 05, 2025 |
| Bid/Offer Closes On | Aug 21, 2025 | Aug 08, 2025 |
| Deemed Date of Allotment | Aug 22, 2025 | Aug 11, 2025 |
| Credit Date | Aug 26, 2025 | Aug 12, 2025 |
| Listing Date | Aug 28, 2025 | Aug 13, 2025 |
Comparison of Kilitch Drugs (india) Rights Issue 2025 and Valiant Laboratories Limited Rights Issue 2025 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.
| Kilitch Drugs (india) Ltd. | Valiant Laboratories Limited | |||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial | Kilitch Drugs (india) Ltd. Financial Information (Restated Consolidated)Kilitch Drugs (india) Ltd.'s revenue increased by 28% and profit after tax (PAT) rose by 84% between the financial year ending with March 31, 2025 and March 31, 2024.
| Valiant Laboratories Limited Financial Information (Restated Consolidated)Valiant Laboratories Limited's revenue decreased by 27% and profit after tax (PAT) dropped by 789% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||
